aEmory Global Diabetes Research Center, Woodruff Health Sciences Center and Emory University, Atlanta, GA, USA bHubert Department of Global Health, Emory University, Atlanta, GA, USA cDepartment of ...
Researchers at McGill University and the Research Institute of the McGill University Health Center (RI-MUHC) have developed a ...
Researchers at McGill University and the Research Institute of the McGill University Health Center (RI-MUHC) have developed a novel device to ...
A new drug is offering hope and time for patients and their families and doubling the survival rate for one of the most deadly cancers. Donna Husar is grateful for the extra time. In 2020, her husband ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...
Pancreatic cancer is one of the most challenging diseases to treat, and while survival rates have improved since the 1970s, they have plateaued in recent years. But two promising drugs in the pipeline ...
Revolution Medicines said its pancreatic cancer drug daraxonrasib succeeded in a Phase 3 trial. RevMed said its drug almost doubled the typical length of survival and slashed the risk of death by 60% ...
Stocks show muted reaction despite moves to blockade the Strait of Hormuz. Investors increasingly view geopolitical shock as temporary, not a long-term market catalyst: analysts. Risks to Hormuz ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results